Office of Research & Development |
![]() ![]() |
Project Number: | I01BX005434-01 |
Title: | COVID19: Optimized Endosome-Targeting Compounds for SARS-CoV-2 and Emerging Coronaviruses |
Principal Investigator: | Joseph ("Stone") Doggett |
Location: | Portland, OR |
Congressional District Code: | 3 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2021 - March 2023 |
FY 2021 Funding Amount: | $127,638 |
Total Award Amount (all years): |
$375,138 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: COVID-19 is a global health crisis that must be countered with the full capacity of government agencies, the private sector and the scientific community. New drugs that are broadly effective against coronaviruses are a crucial tool for ending this pandemic and preventing future coronavirus pandemics. Veterans are particularly at risk for severe COVID-19 due to older age and higher rates of cardiovascular disease. Initial efforts to repurpose drugs for COVID-19 have revived interest in the antivi... |